Product logins

Find logins to all Clarivate products below.


Dee Chaudhary

Director, Consulting

With more than 25 years in life sciences and a passion for patients, Dee Chaudhary is a Director with Clarivate’s Commercial Strategy Consulting practice.  Her work in consulting, and within the biopharmaceutical industry has primarily focused on HUB/patient services, launch readiness, CMS policy impact, customer experience and market access strategy in the hematology and oncology space.

Dee has extensive professional experience with 340B pricing, reimbursement strategy, product positioning and value propositions for oral and infusible agents.  She has led HUB migrations, benchmarking engagements, customer satisfaction projects, omni-channel projects, product differentiation, pricing and positioning efforts, and payer landscape analysis.  Furthermore, Dee has an in-depth understanding of the hematology and oncology market landscape, targeted and cellular therapies, and has a strong interest and experience in other therapeutic areas including cardiology, neuroscience, med tech immunotherapy, and using technology to advance health and access. She has been invited to presented at Asembia, ISPOR and other clinical meetings, and has authored multiple trainings and white papers.

Prior to joining Clarivate, Dee held a variety roles at small and large biopharmaceutical organizations and consulting firms, including National Director of Market Access, Reimbursement and Trade, Senior Director of Customer Experience, and Assistant Director of Reimbursement Consulting. Dee holds a BA from Gustavus Adolphus College in History, and an MBA in Healthcare Administration.


arrow_forward
Get in touch with Dee

Related resources

AI 驱动数据整理:原发性震颤流行病学迎来新方法 AI 驱动数据整理:原发性震颤流行病学迎来新方法
Blog November 17, 2025
AI 驱动数据整理:原发性震颤流行病学迎来新方法
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇 药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
Blog October 13, 2025
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
六家公司为“不可成药”靶点实现精准干预 六家公司为“不可成药”靶点实现精准干预
Blog October 7, 2025
六家公司为“不可成药”靶点实现精准干预
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐 GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐
Blog October 3, 2025
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐